中國網浪潮資訊 近日，紹興企業浙江京新藥業股份有限公司投資6000萬元合作的上海睿泰生物科技股份有限公司研發的自體眼角膜完成臨床試驗。據了解，復明後視力可達到0.4，這是目前世界上復明效果最好的人工角膜。

　　CNCAO NEWS Recently,the Autogenous cornea which was developed by Shanghai Ruitai biotechnology Co., Ltd.,and invested 60 million yuan by the Shaoxing Enterprise Zhejiang Jingxin Pharmaceutical Co., Ltd,completed clinical trial.It is understood that after the restoration, the vision can reach 0.4, which is the best artificial cornea in the world.

　　人工眼角膜，是一項革命性的創新，通過提取口腔黏膜細胞研發的自體眼角膜，也是一項世界性難題。

　　Artificial cornea is a revolutionary innovation, is also a worldwide problem by extracting the cornea, which is developed by oral mucosa cell.

　　據介紹，多年來，京新藥業每年的研發經費超過2億元，多項研發産品走在世界前沿。這是新昌縣營造“政府推動、企業主動、校企互動”的創新創業良好生態的一個景觀。僅2016年，紹興市新昌縣戰略性新興産業産值佔比49.6%，新産品産值率50.81%，研發經費支出佔GDP的4.45%，技術創新、科技産出、創新環境綜合評價均居浙江省前列。

　　According to the introduction, over the years,Jingxin Pharmaceutical Co., Ltd has spent more than two hundred million R&D yuan annually, and many R&D products have been on the cutting edge of the world.This is a good innovative and entrepreneurial landscape of "government promotion, enterprise initiative, school enterprise interaction" in Xinchang county.In 2016 alone, the output value of strategic emerging industries in Shaoxing Xinchang county accounted for 49.6%, and the output value of new products was 50.81%,the R&D expenditure accounted for 4.45% of GDP.The comprehensive evaluation of technological innovation, scientific and technological output, and innovation environment rank the forefront of Zhejiang Province.

　　此外，紹興新昌縣聚焦新興産業，通過人才引進、海外並購、參股合資等方式，使生物醫藥、高端裝備、航空航太等産業也迅速切入全球産業鏈高端。

　　In addition, Shaoxing Xinchang country focus on emerging industries, made the biomedical, high-end equipment, aerospace and other industries also quickly cut into the high-end of the  global industrial chain,through the introduction of talent, overseas mergers and acquisitions, joint ventures and this means.

　　（中國網見習作者魏詩盈 綜合報道 鮑夢依/譯）

來源： 中國網    | 作者：魏詩盈 鮑夢依    | 責編：魏詩盈    審核：張淵

新聞投稿：184042016@qq.com    新聞熱線：13157110107